X

CTS History

01Jul

Research Consortium

CTS Research Consortium was established to further CTS’s leadership in infectious disease research. This collaboration between Vitalant Research Institute, Carter BloodCare, OneBlood, ITxM, New York Blood Center and Bloodworks Northwest will provide a wealth of data for the development of future hypothesis-based research studies. 

About the Author

Related

Source plasma partners

Source plasma partners

By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...

Read More >
Pooled Babesia

Pooled Babesia

Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...

Read More >
Source Plasma / Blood Donor Testing

Source Plasma / Blood Donor Testing

In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).

Read More >
On-time test results

On-time test results

Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...

Read More >
Assay Conversion

Assay Conversion

In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...

Read More >
CTS implements licensesd Zika test

CTS implements licensesd Zika test

Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...

Read More >